Tilray Brands, Inc. Revenue
Tilray Brands, Inc. (TLRY) reported Revenue of $915.45 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-28
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-05-31 was $281.71M, a 25.47% increase year-over-year.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-02-28 was $206.73M, a 11.28% increase year-over-year.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-11-30 was $217.51M, a 3.11% increase year-over-year.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-08-31 was $209.50M, a 4.73% increase year-over-year.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2026 was $915.45M, a 11.46% increase from fiscal 2025.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $821.31M, a 4.10% increase from fiscal 2024.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $788.94M, a 25.80% increase from fiscal 2023.
- Tilray Brands, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $627.12M, a 0.20% decline from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-05-31 | $281.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $488.45M derived: sum of 2 quarters · filed 2026-07-28 | $705.95M derived: sum of 3 quarters · filed 2026-07-28 | $915.45M 10-K · filed 2026-07-28 |
| 2026-02-28 | $206.73M 10-Q · filed 2026-04-01 | $424.24M derived: sum of 2 quarters · filed 2026-04-01 | $633.74M 10-Q · filed 2026-04-01 | $858.27M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $217.51M 10-Q · filed 2026-01-08 | $427.01M 10-Q · filed 2026-01-08 | $651.54M derived: sum of 3 quarters · filed 2026-07-28 | $837.32M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $209.50M 10-Q · filed 2025-10-09 | $434.04M derived: sum of 2 quarters · filed 2026-07-28 | $619.82M derived: sum of 3 quarters · filed 2026-07-28 | $830.77M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $224.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $410.31M derived: sum of 2 quarters · filed 2026-07-28 | $621.26M derived: sum of 3 quarters · filed 2026-07-28 | $821.31M 10-K · filed 2026-07-28 |
| 2025-02-28 | $185.78M 10-Q · filed 2026-04-01 | $396.73M derived: sum of 2 quarters · filed 2026-04-01 | $596.77M 10-Q · filed 2026-04-01 | $826.66M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $210.95M 10-Q · filed 2026-01-08 | $410.99M 10-Q · filed 2026-01-08 | $640.88M derived: sum of 3 quarters · filed 2026-07-28 | $829.22M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $200.04M 10-Q · filed 2025-10-09 | $429.93M derived: sum of 2 quarters · filed 2026-07-28 | $618.27M derived: sum of 3 quarters · filed 2026-07-28 | $812.04M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $229.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $418.22M derived: sum of 2 quarters · filed 2026-07-28 | $611.99M derived: sum of 3 quarters · filed 2026-07-28 | $788.94M 10-K · filed 2026-07-28 |
| 2024-02-29 | $188.34M 10-Q · filed 2025-04-08 | $382.11M derived: sum of 2 quarters · filed 2025-04-08 | $559.06M 10-Q · filed 2025-04-08 | $743.25M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $193.77M 10-Q · filed 2025-01-10 | $370.72M 10-Q · filed 2025-01-10 | $554.91M derived: sum of 3 quarters · filed 2025-07-29 | $700.50M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $176.95M 10-Q · filed 2024-10-10 | $361.14M derived: sum of 2 quarters · filed 2025-07-29 | $506.73M derived: sum of 3 quarters · filed 2025-07-29 | $650.86M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $184.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $329.78M derived: sum of 2 quarters · filed 2025-07-29 | $473.91M derived: sum of 3 quarters · filed 2025-07-29 | $627.12M 10-K · filed 2025-07-29 |
| 2023-02-28 | $145.59M 10-Q · filed 2024-04-09 | $289.73M derived: sum of 2 quarters · filed 2024-04-09 | $442.94M 10-Q · filed 2024-04-09 | $596.26M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $144.14M 10-Q · filed 2024-01-09 | $297.35M 10-Q · filed 2024-01-09 | $450.67M derived: sum of 3 quarters · filed 2024-10-10 | $602.54M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $153.21M 10-Q · filed 2024-10-10 | $306.54M derived: sum of 2 quarters · filed 2024-10-10 | $458.41M derived: sum of 3 quarters · filed 2024-10-10 | $613.56M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $153.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $305.20M derived: sum of 2 quarters · filed 2024-07-30 | $460.35M derived: sum of 3 quarters · filed 2024-07-30 | $628.37M 10-K · filed 2024-07-30 |
| 2022-02-28 | $151.87M 10-Q · filed 2023-04-10 | $307.02M derived: sum of 2 quarters · filed 2023-04-10 | $475.05M 10-Q · filed 2023-04-10 | $617.28M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $155.15M 10-Q · filed 2023-01-09 | $323.18M 10-Q · filed 2023-01-09 | $465.41M derived: sum of 3 quarters · filed 2023-07-26 | $589.31M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $168.02M 10-Q · filed 2022-10-07 | $310.26M derived: sum of 2 quarters · filed 2023-07-26 | $434.16M derived: sum of 3 quarters · filed 2023-07-26 | $563.62M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-05-31 | $142.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $266.14M derived: sum of 2 quarters · filed 2023-07-26 | $395.60M derived: sum of 3 quarters · filed 2023-07-26 | $513.09M 10-K · filed 2023-07-26 |
| 2021-02-28 | $123.90M 10-Q · filed 2022-04-06 | $253.36M derived: sum of 2 quarters · filed 2022-04-06 | $370.85M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | $129.46M 10-Q · filed 2022-01-10 | $246.95M 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $117.49M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | $405.33M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | $179.30M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |